Related Experiment Video

Updated: Jun 6, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Latent tuberculosis in children: diagnosis and management

Meenu Singh1, Arushi Gahlot Saini, Nidhi Anil

  • 1Department of Pediatrics, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Indian Journal of Pediatrics
|December 4, 2010
PubMed

Insights

Children with tuberculosis (TB) require focused screening and treatment for latent infection due to their significant disease burden. New diagnostic tools are crucial for effective control in high-burden settings.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) control in children is challenging due to paucibacillary disease.
  • Children contribute significantly to TB morbidity, mortality, and disease transmission.
  • Risk-factor based screening and treatment of latent TB infection (LTBI) in children are critical.

Purpose of the Study:

  • To review the diagnosis and treatment of latent TB infection in children.
  • To highlight the importance of effective screening and management strategies.
  • To discuss emerging diagnostic modalities for pediatric TB.

Main Methods:

  • Review of current literature on pediatric latent TB infection.
  • Analysis of diagnostic modalities including interferon-gamma release assays (IGRAs) and skin tests.
  • Discussion of challenges and opportunities in resource-limited settings.

Main Results:

  • Latent TB infection in children necessitates careful management to reduce disease burden and transmission.
  • Interferon-gamma release assays (IGRAs) have limited utility in low-income, high-burden settings currently.
  • Improved skin tests using specific mycobacterial antigens show promise for resource-limited settings.

Conclusions:

  • Effective control of pediatric tuberculosis requires robust screening and treatment protocols for latent infection.
  • Further research is needed to optimize diagnostic tools, particularly for resource-limited settings.
  • Development of novel TB skin tests is a promising avenue for improving pediatric TB management globally.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...